The joumal uses Crossref ited-by service counts times cited of published aricles. Citedby allows Crossref members to find out who is citing their conten. This is the Citing Article List of “Selecting the best-value biosimilar in emerging countries”.

No.	Publication Date	Citing Article
1	2026	Biosimilars: state of the art in the treatment of rheumatic diseases, Exploration of Musculoskeletal Diseases. 1;4:1. https://doi.org/10.37349/emd.2026.1007115